Amsterdam, 06 September 2007 – Elsevier in partnership with the European Crohn’s and Colitis Organisation (ECCO) is set to launch the Journal of Crohn’s and Colitis, a new international journal on inflammatory bowel diseases (IBD). This quarterly journal will be the official journal of the ECCO society and the first print issue will be available in September 2007.
The Journal of Crohn's and Colitis is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to inflammatory bowel diseases. The journal will publish original articles, review papers, editorials, leading articles, view points, case reports, innovative methods and letters to the editor. Supplemental issues of the journal will be published under a separate title, Journal of Crohn's and Colitis Supplements.
Miquel Gassull, M.D., Ph.D., Hospital Universitari Germans Trias I Pujol in Badalona, Spain and president of ECCO, will serve as the Editor-in-Chief of the new journal. The Editor-in-Chief is joined by a group of prestigious associate editors including Yehuda Chowers, Jean-Frédéric Colombel, Daan Hommes, Jack Satsangi, Stefan Schreiber, Séverine Vermeire and the consensus and guidelines editors Eduard Stange and Simon Travis.
“Although it is the official journal of ECCO, the Journal of Crohn’s and Colitis is open to everyone in the world interested and working in the field of inflammatory bowel diseases” commented Miquel Gassull. “This will become a high quality journal, opening an interactive pathway between clinicians and basic scientists, publishing the best reviews, clinical trials, good observational data, modern epidemiology and relevant breaking news on the diagnosis and therapy of IBD.”
Members of ECCO will receive a subscription to the Journal of Crohn’s and Colitis as a benefit of their membership. Members and individual subscribers will be able to access the entire contents of each issue on the journal’s website (http://ww.ecco-jccjournal.org/). The journal will also be accessible through Elsevier’s online database ScienceDirect (http://www.sciencedirect.com/), the world’s largest electronic collection of science, technology and medicine full-text and bibliographic information.
About ECCO
The European Crohn’s and Colitis Organisation (ECCO) was founded in 2001 as the European association of national inflammatory bowel diseases (IBD) study groups. The mission of ECCO (http://www.ecco-ibd.eu/) is to strive for optimised care for patients with IBD in all aspects. To this end, ECCO will adopt and further all efforts that lead to an improvement in the use of current therapies and procedures, develop guidelines with the highest possible process and content quality, and define better and more valid outcome parameters for the therapy of IBD. In addition, ECCO promotes the specialist, postgraduate education in IBD and scientific projects in IBD.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).